Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

ProMIS Neurosciences Inc.

PMN
Current price
0.99 USD -0.05 USD (-4.81%)
Last closed 1.07 USD
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 31 980 472 USD
Yield for 12 month -34.00 %
1Y
3Y
5Y
10Y
15Y
PMN
21.11.2021 - 28.11.2021

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates comprise of PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada. Address: 1920 Yonge Street, Toronto, ON, Canada, M4S 3E2

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

8.75 USD

P/E ratio

Dividend Yield

Current Year

Last Year

+8 139 USD

Current Quarter

Last Quarter

+6 276 USD

Current Year

-10 444 957 USD

Last Year

-21 781 221 USD

Current Quarter

Last Quarter

-11 745 USD

Key Figures PMN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -11 153 589 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -480.73 %
PEG Ratio
Return On Equity TTM -1098.51 %
Wall Street Target Price 8.75 USD
Revenue TTM 7 558 USD
Book Value -0.12 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM -16 087 168 USD
Earnings per share -0.54 USD
Diluted Eps TTM -0.54 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics PMN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History PMN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:60
Payout Ratio
Last Split Date 28.06.2022
Dividend Date

Stock Valuation PMN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 3868.0788
Price Sales TTM 5168.1934
Enterprise Value EBITDA -1.7408
Price Book MRQ 300.0371

Financials PMN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PMN

For 52 weeks

0.92 USD 3.1 USD
50 Day MA 1.15 USD
Shares Short Prior Month 128 009
200 Day MA 1.66 USD
Short Ratio 1.88
Shares Short 137 768
Short Percent 0.6 %